Literature DB >> 32741893

Oxidative Stress and Inflammation as Predictors of Mortality and Cardiovascular Events in Hemodialysis Patients: The DREAM Cohort.

Keyaki Sasaki1, Tetsuo Shoji2,3, Daijiro Kabata4, Ayumi Shintani4, Yujiro Okute1, Shoko Tsuchikura5, Naoko Shimomura5, Yoshihiro Tsujimoto5, Shinya Nakatani1, Katsuhito Mori6, Atsushi Shioi2,3, Masaaki Inaba1,3,6, Masanori Emoto1.   

Abstract

AIM: Both oxidative stress and inflammation are involved in the pathogenesis of cardiovascular disease (CVD). The serum level of derivatives of reactive oxygen metabolites (d-ROMs) is a measure of the total amount of hydroperoxides serving as a marker of oxidative stress. We investigated whether d-ROMs could predict the clinical outcomes in hemodialysis patients and whether the associations of d-ROMs with the outcomes are independent of a marker of inflammation, C-reactive protein (CRP).
METHODS: This was a prospective cohort study in hemodialysis patients. The key exposures were the serum levels of d-ROMs and CRP. The outcome measures were all-cause mortality and new CVD events.
RESULTS: A total of 517 patients were analyzed. d-ROMs correlated positively with CRP. During follow-up for 5 years, 107 patients died, and 190 patients experienced new CVD events. In the Kaplan-Meier analyses, both higher d-ROMs and higher CRP levels predicted higher risks for mortality and CVD events. By Cox proportional-hazard regression analysis adjusted for potential confounders excluding CRP, d-ROMs exhibited a significant association with all-cause mortality, but this association was no longer significant after further adjustment for CRP. Using the same model, CRP exhibited a significant association with all-cause mortality, but this association was no longer significant after further adjustment for d-ROMs. When we analyzed new CVD events as the outcome, CRP was a significant predictor, whereas the level of d-ROMs was not.
CONCLUSIONS: Although d-ROMs predicted mortality and CVD events in unadjusted models, the associations of d-ROMs with these outcomes were not independent of CRP. Oxidative stress and inflammation appear to share common causal pathways.

Entities:  

Keywords:  Cardiovascular disease; Clinical epidemiology; Hemodialysis; Oxidative stress; d-ROMs

Year:  2020        PMID: 32741893      PMCID: PMC8049144          DOI: 10.5551/jat.56069

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  41 in total

1.  Serum myeloperoxidase and mortality in maintenance hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Marie-Luise Brennan; Stanley L Hazen
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

2.  Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.

Authors:  Yukinobu Kuwamura; Tetsuo Shoji; Yujiro Okute; Yuko Yamazaki; Koka Motoyama; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Yoshihiro Tsujimoto; Atsushi Shioi; Masanori Emoto; Masaaki Inaba
Journal:  J Ren Nutr       Date:  2017-10-28       Impact factor: 3.655

Review 3.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 4.  Oxidative stress: oxidants and antioxidants.

Authors:  H Sies
Journal:  Exp Physiol       Date:  1997-03       Impact factor: 2.969

5.  Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies.

Authors:  Yang Xuan; Martin Bobak; Ankita Anusruti; Eugène H J M Jansen; Andrzej Pająk; Abdonas Tamosiunas; Kai-Uwe Saum; Bernd Holleczek; Xin Gao; Hermann Brenner; Ben Schöttker
Journal:  Eur J Epidemiol       Date:  2018-11-07       Impact factor: 8.082

6.  Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.

Authors:  G J Handelman; M F Walter; R Adhikarla; J Gross; G E Dallal; N W Levin; J B Blumberg
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

7.  Advanced atherosclerosis in predialysis patients with chronic renal failure.

Authors:  Tetsuo Shoji; Masanori Emoto; Tsutomu Tabata; Eiji Kimoto; Kayo Shinohara; Kiyoshi Maekawa; Takahiko Kawagishi; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

8.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

9.  Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.

Authors:  Lara B Pupim; Jonathan Himmelfarb; Ellen McMonagle; Yu Shyr; T Alp Ikizler
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

10.  Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Authors:  Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Journal:  N Engl J Med       Date:  2009-03-30       Impact factor: 91.245

View more
  10 in total

1.  The Core Role of Neutrophil-Lymphocyte Ratio to Predict All-Cause and Cardiovascular Mortality: A Research of the 2005-2014 National Health and Nutrition Examination Survey.

Authors:  Linguo Gu; Zhenkun Xia; Bei Qing; Hongzuo Chen; Wei Wang; Ying Chen; Yunchang Yuan
Journal:  Front Cardiovasc Med       Date:  2022-05-12

2.  Comorbidity burden may explain adiponectin's paradox as a marker of increased mortality risk in hemodialysis patients.

Authors:  Ilia Beberashvili; Tamar Cohen-Cesla; Amin Khatib; Ramzia Abu Hamad; Ada Azar; Kobi Stav; Shai Efrati
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

3.  Association of Reduced Free T3 to Free T4 Ratio with Lower Serum Creatinine in Japanese Hemodialysis Patients.

Authors:  Masaaki Inaba; Katsuhito Mori; Yoshihiro Tsujimoto; Shinsuke Yamada; Yuko Yamazaki; Masanori Emoto; Tetsuo Shoji
Journal:  Nutrients       Date:  2021-12-17       Impact factor: 5.717

Review 4.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

5.  Anthropometric parameters of obesity can be alternative biomarkers for the potential cardiac dysfunction in obese children.

Authors:  Jing Sun; Li Wang; Yingjiong Lin; Yunfeng Liu; Fei Liu; Xumei Liu; Wenyan Dong; Wenqian Cai; Huimin Chen; Minhua Xiao; Hongfeng Luo; Xihong Liu; Jinzhu Duan
Journal:  Front Cardiovasc Med       Date:  2022-08-18

6.  Oxidative Stress Biomarkers and Their Association with Mortality among Patients Infected with SARS-CoV-2 in Mexico.

Authors:  Azalia Avila-Nava; Alfredo Geovanny Pech-Aguilar; Roberto Lugo; Isabel Medina-Vera; Martha Guevara-Cruz; Ana Ligia Gutiérrez-Solis
Journal:  Oxid Med Cell Longev       Date:  2022-06-17       Impact factor: 7.310

7.  Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.

Authors:  Pengbo Wang; Xiaofan Guo; Ying Zhou; Zhao Li; Shasha Yu; Yingxian Sun; Yu Hua
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-09       Impact factor: 6.055

8.  Protective Effect of Autologous Arteriovenous Fistulae Against Oxidative Stress in Hemodialyzed Patients.

Authors:  Rodolfo A Valtuille; Guillermo Rossi; Eliana Gimenez
Journal:  Cureus       Date:  2021-06-02

9.  Is Oxidative Stress a Key Player for Progression of Cardiovascular Disease in Dialysis Patients?

Authors:  Hideki Fujii
Journal:  J Atheroscler Thromb       Date:  2020-09-25       Impact factor: 4.928

10.  Associations of Baseline and Changes in Leukocyte Counts with Incident Cardiovascular Events: The Dongfeng-Tongji Cohort Study.

Authors:  Qiuhong Wang; Qiang Guo; Lue Zhou; Wending Li; Yu Yuan; Wenhui Lei; Kang Liu; Man Xu; Tingyue Diao; Hui Gao; Meian He; Huan Guo; Handong Yang; Xiaomin Zhang; Tangchun Wu
Journal:  J Atheroscler Thromb       Date:  2021-07-26       Impact factor: 4.394

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.